Pulmonology · 1 h ago
Alveolar stem cells contribute to bronchiolar repair in mice
A Nature study using genetic lineage tracing in mice found that alveolar type 2 cells migrate into injured bronchioles and generate airway epithelial cells. Experiments implicated SPP1–ITGB1 signalling in migration and Notch signalling in differentiation into club cells; clinical applicability remains unestablished.
- Selective lineage tracing distinguished AT2 cells from bronchoalveolar stem cells.
- AT2 cells generated club and ciliated cells after mouse airway injury.
- SPP1–ITGB1 regulated migration; Notch promoted club-cell differentiation.
- Human therapeutic relevance remains unestablished.
Alveolar and airway epithelial cells occupy distinct lung compartments, but whether alveolar cells contribute to airway repair has been unclear. In a mouse study published in Nature, researchers developed selective lineage-tracing approaches to track alveolar type 2 (AT2) cells after bronchiolar injury, distinguishing them from bronchoalveolar stem cells that can confound conventional tracing.
After selective diphtheria toxin-mediated elimination of club cells and bronchoalveolar stem cells, labelled AT2 cells migrated into bronchioles and generated epithelial cells, including club and ciliated cells. At four weeks, 77.42% ± 4.71% of new club cells originated from AT2 cells in this experiment (mean ± standard deviation; five mice). AT2-derived cells entered bronchioles through the bronchioalveolar-duct junction or trans-bronchiolar channels.
Mechanistic experiments indicated that infiltrating immune cells secreted SPP1, directing AT2 migration through integrin ITGB1. Signals from resident ciliated cells activated Notch, promoting differentiation into club cells through a Cldn4-expressing intermediate state. Blocking SPP1 or ITGB1 impaired migration, whereas inhibiting Notch prevented club-cell differentiation.
The findings identify a potential repair mechanism relevant to airway epithelial injury. However, they derive from experimental mouse injury models, including selective cell ablation, rather than patients. The reported regeneration percentages are model-specific and do not establish therapeutic efficacy or safety in human airway disease.
Is this summary clinically accurate?
Help fellow clinicians: your rating sends inaccurate summaries straight to our editors.
Sign in to rate this summary →Source
Nature: Alveolar stem cells transdifferentiate to drive bronchiolar regeneration ↗This is an automated AI-condensed summary that has not yet been reviewed by an editor. Always consult the full item at the original source.
